PATENT CLAIM ANALYSIS

Application Number: 16081260
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["544", "239000"]

Abstract:
The present invention provides an agent for treating malignant tumor, comprising a compound of formula (1): wherein R 1  to R 4  are hydrogen atom, halogen, or etc., Y is optionally-substituted alkylene group or etc.

Claim (Index 3):
The compound of  claim 1  or a pharmaceutically acceptable salt thereof, wherein R 1  to R 4  are independently hydrogen atom, halogen, OH, CN, C 1-4  alkyl group, halogenated C 1-4  alkyl group, C 2-4  alkenyl group, C 1-4  alkoxy group, or halogenated C 1-4  alkoxy group.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.16216
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12739262', '13796437', '13388884', '10472412', '13800907']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7857753886003961
- 35 USC 102 Novelty (BERT): 0.529838310263555
- Combined Prediction Score: 0.760181680766712
- Mean Citation Score: 330.37364
- Max Citation Score: 345.36115
- Similarity Product: 263.3157437446594

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test